Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Predictive Performance of NEWS-2 and NEWS-Calcium Scores for In-Hospital Mortality in Older Patients With Acute Pancreatitis (NEWS)

6 juin 2026 mis à jour par: Antalya Health Sciences University

Comparison of the Predictive Performance of NEWS-2 and NEWS-Calcium Scores on In-Hospital Mortality in Patients Aged 65 Years and Older Diagnosed With Acute Pancreatitis in the Emergency Department.

Acute pancreatitis is an important gastrointestinal emergency that may lead to mortality, particularly in older patients. This retrospective, single-center observational prognostic validation study aims to compare the predictive performance of the National Early Warning Score 2 (NEWS-2) and NEWS-Calcium scores for in-hospital mortality in patients aged 65 years and older diagnosed with acute pancreatitis in the emergency department.

Electronic medical records of eligible patients will be reviewed retrospectively. Demographic characteristics, vital signs, serum calcium levels, clinical outcomes, intensive care unit admission, organ failure, length of hospital stay, and in-hospital mortality will be recorded. NEWS-2 will be calculated using vital parameters at admission, while the NEWS-Calcium score will be obtained by adding a calcium-based score to NEWS-2.

The primary outcome will be in-hospital mortality. Secondary outcomes will include intensive care unit admission, severe acute pancreatitis, persistent organ failure, and length of hospital stay. The predictive performances of the scores will be compared using ROC curve analysis, AUC values, and the DeLong test. This study aims to identify the most appropriate early prognostic score for older patients with acute pancreatitis and to support clinical decision-making in emergency settings.

Aperçu de l'étude

Description détaillée

Acute pancreatitis is a common gastrointestinal emergency that may be associated with significant morbidity and mortality, particularly in older patients. In individuals aged 65 years and older, reduced physiological reserve, increased comorbidity burden, and delayed clinical deterioration may make early risk stratification more important in the emergency department.

The National Early Warning Score 2 (NEWS-2) is a widely used clinical scoring system based on routinely measured physiological parameters, including respiratory rate, oxygen saturation, systolic blood pressure, pulse rate, level of consciousness, temperature, and supplemental oxygen use. Calcium abnormalities, especially hypocalcemia, may also be associated with disease severity and poor outcomes in acute pancreatitis. Therefore, a calcium-integrated scoring approach may improve early prognostic assessment in this patient population.

This study is designed as a single-center, retrospective, observational prognostic validation study. The study will include patients aged 65 years and older who were admitted to the emergency department and diagnosed with acute pancreatitis during the predefined study period. Eligible patients will be identified through electronic medical records. Demographic characteristics, comorbidities, vital signs at emergency department admission, laboratory parameters including serum calcium levels, clinical outcomes, intensive care unit admission, organ failure status, length of hospital stay, and in-hospital mortality will be recorded.

The NEWS-2 score will be calculated using physiological parameters measured at the time of emergency department admission. The NEWS-Calcium score will be calculated by adding a calcium-based component to the NEWS-2 score according to serum total or corrected calcium levels. The primary outcome of the study will be in-hospital mortality. Secondary outcomes will include intensive care unit admission, development of severe acute pancreatitis, persistent organ failure, and length of hospital stay.

The main objective of this study is to compare the predictive performance of NEWS-2 and NEWS-Calcium scores for in-hospital mortality in older patients with acute pancreatitis. Receiver operating characteristic (ROC) curve analysis will be used to evaluate the prognostic performance of each score. The area under the curve (AUC), sensitivity, specificity, positive predictive value, negative predictive value, and optimal cut-off values will be calculated. The AUC values of NEWS-2 and NEWS-Calcium will be compared using the DeLong test.

This study is expected to provide evidence on whether the addition of serum calcium to NEWS-2 improves early mortality prediction in geriatric patients with acute pancreatitis. The findings may contribute to early risk stratification, clinical decision-making, and appropriate allocation of intensive care resources in the emergency department.

Type d'étude

Observationnel

Inscription (Estimé)

350

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • konyaaltı
      • Antalya, konyaaltı, Turquie (Türkiye), 07100
        • University of Health Sciences, Antalya Training and Research Hospital
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte plus âgé

Accepte les volontaires sains

Non

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

The study population will consist of patients aged 65 years and older who were admitted to the emergency department and diagnosed with acute pancreatitis during the predefined study period. Eligible patients will be identified retrospectively through electronic medical records. Patients with available admission vital signs, serum calcium levels, and in-hospital outcome data will be included. Patients with missing data required for calculation of NEWS-2 or NEWS-Calcium scores, unavailable outcome data, or transfer before outcome assessment will be excluded. Only the first eligible admission will be analyzed for patients with recurrent admissions.

La description

Inclusion Criteria:

  • Age 65 years or older.
  • Admission to the emergency department with a diagnosis of acute pancreatitis during the study period.
  • Diagnosis of acute pancreatitis established according to clinical presentation, serum pancreatic enzyme levels, and/or imaging findings.
  • Availability of admission vital parameters required to calculate the National Early Warning Score 2 (NEWS-2).
  • Availability of serum calcium measurement at emergency department admission.
  • Availability of in-hospital clinical outcome data.

Exclusion Criteria:

  • Age younger than 65 years.
  • Absence of a confirmed diagnosis of acute pancreatitis.
  • Missing data required to calculate NEWS-2 or NEWS-Calcium scores.
  • Missing serum calcium measurement at admission.
  • Incomplete medical records or unavailable in-hospital outcome data.
  • Transfer to another hospital before clinical outcome assessment.
  • Recurrent admissions during the study period; only the first eligible admission will be analyzed.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Patients Aged 65 Years and Older with Acute Pancreatitis
This cohort will include patients aged 65 years and older diagnosed with acute pancreatitis in the emergency department. Data will be collected retrospectively from electronic medical records. No intervention will be administered. NEWS-2 and NEWS-Calcium scores will be calculated using admission data, and their predictive performance for in-hospital mortality will be compared.
he National Early Warning Score 2 (NEWS-2) will be calculated retrospectively using physiological parameters recorded at emergency department admission, including respiratory rate, oxygen saturation, systolic blood pressure, pulse rate, level of consciousness, body temperature, and supplemental oxygen use. No intervention will be administered to patients as part of this study.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
In-Hospital Mortality
Délai: From emergency department admission to hospital discharge or in-hospital death, up to 30 days.
n-hospital mortality will be defined as death occurring during the index hospitalization among patients aged 65 years and older diagnosed with acute pancreatitis in the emergency department. Mortality status will be obtained retrospectively from electronic medical records.
From emergency department admission to hospital discharge or in-hospital death, up to 30 days.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

15 juillet 2026

Achèvement primaire (Estimé)

15 septembre 2026

Achèvement de l'étude (Estimé)

15 octobre 2026

Dates d'inscription aux études

Première soumission

6 juin 2026

Première soumission répondant aux critères de contrôle qualité

6 juin 2026

Première publication (Réel)

11 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

11 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

6 juin 2026

Dernière vérification

1 juin 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data will not be shared. This is a retrospective study based on electronic medical records, and individual-level patient data will not be made available to other researchers due to confidentiality, ethical, and institutional data protection regulations. Only aggregated and anonymized study results will be reported.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner